Re AGH's $18mn, they are not producing cashflow atm so this will diminish over time.
IHL is producing cashflow rising from quarter to quarter and then you have to consider the options.
Cannvalate has 120mn unquoted options with prices ranging from 2c to 14c, interestingly enough the larger chunks of options are on offer at the higher values. The Cannvalate options expire between end of this calendar year and end of 2020. If all are exercised alongside the rising SP then they will generate $10mn im cash for IHL.
In addition we have the quoted options being 256mn at 0.04 also expiring late next next year. If fully exercised then these will bring in another $10mn in cash.
So that's north of $20mn in cash just waiting to be claimed.
Sure that is some heavy dilution, but, by then Cannvalate will be a major shareholder and the supply business should be firing on all cylinders with IHL sitting on $20mn in cash.
Even with the option exercise dilution a mkt cap of $200mn would be be worth around 21.5c a share and that would only put us equal with where AGH is now, IHL, under this scenario, would be miles ahead of AGH so would deserve an even higher mkt cap than $200mn imo.
All of which explains why the OBs are my biggest portfolio position these days.
EB
- Forums
- ASX - By Stock
- IHL Chart Technicals
Re AGH's $18mn, they are not producing cashflow atm so this will...
-
-
- There are more pages in this discussion • 135 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)